These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 24662830)

  • 1. Novel small molecules disrupting Hec1/Nek2 interaction ablate tumor progression by triggering Nek2 degradation through a death-trap mechanism.
    Hu CM; Zhu J; Guo XE; Chen W; Qiu XL; Ngo B; Chien R; Wang YV; Tsai CY; Wu G; Kim Y; Lopez R; Chamberlin AR; Lee EY; Lee WH
    Oncogene; 2015 Mar; 34(10):1220-30. PubMed ID: 24662830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphorylation of the mitotic regulator protein Hec1 by Nek2 kinase is essential for faithful chromosome segregation.
    Chen Y; Riley DJ; Zheng L; Chen PL; Lee WH
    J Biol Chem; 2002 Dec; 277(51):49408-16. PubMed ID: 12386167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small molecule targeting the Hec1/Nek2 mitotic pathway suppresses tumor cell growth in culture and in animal.
    Wu G; Qiu XL; Zhou L; Zhu J; Chamberlin R; Lau J; Chen PL; Lee WH
    Cancer Res; 2008 Oct; 68(20):8393-9. PubMed ID: 18922912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphorylation of the Ndc80 complex protein, HEC1, by Nek2 kinase modulates chromosome alignment and signaling of the spindle assembly checkpoint.
    Wei R; Ngo B; Wu G; Lee WH
    Mol Biol Cell; 2011 Oct; 22(19):3584-94. PubMed ID: 21832156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological evaluation of a series of novel inhibitor of Nek2/Hec1 analogues.
    Qiu XL; Li G; Wu G; Zhu J; Zhou L; Chen PL; Chamberlin AR; Lee WH
    J Med Chem; 2009 Mar; 52(6):1757-67. PubMed ID: 19243176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the biological activity of a potent small molecule Hec1 inhibitor TAI-1.
    Huang LY; Lee YS; Huang JJ; Chang CC; Chang JM; Chuang SH; Kao KJ; Tsai YJ; Tsai PY; Liu CW; Lin HS; Lau JY
    J Exp Clin Cancer Res; 2014 Jan; 33(1):6. PubMed ID: 24401611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of T-1101 tosylate as a first-in-class clinical candidate for Hec1/Nek2 inhibition in cancer therapy.
    Chuang SH; Lee YE; Huang LYL; Chen CK; Lai CL; Lin YH; Yang JY; Yang SC; Chang LH; Chen CH; Liu CW; Lin HS; Lee YR; Huang KP; Fu KC; Jen HM; Lai JY; Jian PS; Wang YC; Hsueh WY; Tsai PY; Hong WH; Chang CC; Wu DZ; Wu J; Chen MH; Yu KM; Chern CY; Chang JM; Lau JYN; Huang JJ
    Eur J Med Chem; 2020 Apr; 191():112118. PubMed ID: 32113126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of 4-aryl-N-arylcarbonyl-2-aminothiazoles as Hec1/Nek2 inhibitors. Part I: optimization of in vitro potencies and pharmacokinetic properties.
    Lee YS; Chuang SH; Huang LY; Lai CL; Lin YH; Yang JY; Liu CW; Yang SC; Lin HS; Chang CC; Lai JY; Jian PS; Lam K; Chang JM; Lau JY; Huang JJ
    J Med Chem; 2014 May; 57(10):4098-110. PubMed ID: 24773549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of Hec1 as a novel approach for treatment of primary liver cancer.
    Huang LY; Chang CC; Lee YS; Huang JJ; Chuang SH; Chang JM; Kao KJ; Lau GM; Tsai PY; Liu CW; Lin HS; Gish RG; Lau JY
    Cancer Chemother Pharmacol; 2014 Sep; 74(3):511-20. PubMed ID: 25038613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical activity of MBM-5 in gastrointestinal cancer by inhibiting NEK2 kinase activity.
    Fang Y; Kong Y; Xi J; Zhu M; Zhu T; Jiang T; Hu W; Ma M; Zhang X
    Oncotarget; 2016 Nov; 7(48):79327-79341. PubMed ID: 27764815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small molecules targeted to the microtubule-Hec1 interaction inhibit cancer cell growth through microtubule stabilization.
    Ferrara M; Sessa G; Fiore M; Bernard F; Asteriti IA; Cundari E; Colotti G; Ferla S; Desideri M; Buglioni S; Trisciuoglio D; Del Bufalo D; Brancale A; Degrassi F
    Oncogene; 2018 Jan; 37(2):231-240. PubMed ID: 28925395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mitotic checkpoint kinase NEK2A regulates kinetochore microtubule attachment stability.
    Du J; Cai X; Yao J; Ding X; Wu Q; Pei S; Jiang K; Zhang Y; Wang W; Shi Y; Lai Y; Shen J; Teng M; Huang H; Fei Q; Reddy ES; Zhu J; Jin C; Yao X
    Oncogene; 2008 Jul; 27(29):4107-14. PubMed ID: 18297113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitotic perturbations induced by Nek2 overexpression require interaction with TRF1 in breast cancer cells.
    Lee J; Gollahon L
    Cell Cycle; 2013 Dec; 12(23):3599-614. PubMed ID: 24091727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of Nek2 by small molecules affects proteasome activity.
    Meng L; Carpenter K; Mollard A; Vankayalapati H; Warner SL; Sharma S; Tricot G; Zhan F; Bearss DJ
    Biomed Res Int; 2014; 2014():273180. PubMed ID: 25313354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LIN9 and NEK2 Are Core Regulators of Mitotic Fidelity That Can Be Therapeutically Targeted to Overcome Taxane Resistance.
    Roberts MS; Sahni JM; Schrock MS; Piemonte KM; Weber-Bonk KL; Seachrist DD; Avril S; Anstine LJ; Singh S; Sizemore ST; Varadan V; Summers MK; Keri RA
    Cancer Res; 2020 Apr; 80(8):1693-1706. PubMed ID: 32054769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphorylation of microtubule-binding protein Hec1 by mitotic kinase Aurora B specifies spindle checkpoint kinase Mps1 signaling at the kinetochore.
    Zhu T; Dou Z; Qin B; Jin C; Wang X; Xu L; Wang Z; Zhu L; Liu F; Gao X; Ke Y; Wang Z; Aikhionbare F; Fu C; Ding X; Yao X
    J Biol Chem; 2013 Dec; 288(50):36149-59. PubMed ID: 24187132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nek2 targets the mitotic checkpoint proteins Mad2 and Cdc20: a mechanism for aneuploidy in cancer.
    Liu Q; Hirohashi Y; Du X; Greene MI; Wang Q
    Exp Mol Pathol; 2010 Apr; 88(2):225-33. PubMed ID: 20034488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-terminus-modified Hec1 suppresses tumour growth by interfering with kinetochore-microtubule dynamics.
    Orticello M; Fiore M; Totta P; Desideri M; Barisic M; Passeri D; Lenzi J; Rosa A; Orlandi A; Maiato H; Del Bufalo D; Degrassi F
    Oncogene; 2015 Jun; 34(25):3325-35. PubMed ID: 25132262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benzimidazole inhibitors induce a DFG-out conformation of never in mitosis gene A-related kinase 2 (Nek2) without binding to the back pocket and reveal a nonlinear structure-activity relationship.
    Solanki S; Innocenti P; Mas-Droux C; Boxall K; Barillari C; van Montfort RL; Aherne GW; Bayliss R; Hoelder S
    J Med Chem; 2011 Mar; 54(6):1626-39. PubMed ID: 21366329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic melting pot of never in mitosis gene a related kinase 2 (Nek2): a perspective on Nek2 as an oncology target and recent advancements in Nek2 small molecule inhibition.
    Frett B; Brown RV; Ma M; Hu W; Han H; Li HY
    J Med Chem; 2014 Jul; 57(14):5835-44. PubMed ID: 24517277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.